These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3343758)

  • 1. Bone resorption induced by transplanted bladder tumor (MBT-2) in mice.
    Nemoto R; Uchida K; Tsutsumi M; Koiso K; Satoh T
    J Urol; 1988 Mar; 139(3):650-2. PubMed ID: 3343758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local bone resorption induced by serially transplantable human renal cell carcinoma in nude mice.
    Nemoto R; Kanoh S; Koiso K; Shigenori S; Kabashima T; Haebara H
    Urol Int; 1987; 42(5):326-9. PubMed ID: 3433578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice.
    Nemoto R; Satou S; Miyagawa I; Koiso K
    Cancer; 1991 Feb; 67(3):643-8. PubMed ID: 1898709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of MBT-2 bladder carcinoma-induced osteolysis to various agents.
    Nemoto R; Satou S; Mochizuki T; Okabe K
    Cancer; 1992 May; 69(9):2316-21. PubMed ID: 1562978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment of a model to evaluate inhibition of bone resorption induced by bladder tumor (MBT-2) in mice].
    Nishijima Y; Nemoto R; Koiso K
    Nihon Hinyokika Gakkai Zasshi; 1990 May; 81(5):694-700. PubMed ID: 2376925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pyridinoline crosslinks as markers of tumour-induced bone resorption.
    Nemoto R; Nakamura I; Nishijima Y; Shiobara K; Shimizu M; Takehara T; Ohta T; Kiyoki M
    Br J Urol; 1997 Aug; 80(2):274-80. PubMed ID: 9284202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by a new bisphosphonate (YM175) of bone resorption induced by the MBT-2 tumour of mice.
    Nemoto R; Nishijima Y; Uchida K; Koiso K
    Br J Cancer; 1993 May; 67(5):893-7. PubMed ID: 8494721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium.
    Nemoto R; Uchida K; Tsutsumi M; Koiso K; Satou S; Satou T
    J Cancer Res Clin Oncol; 1987; 113(6):539-43. PubMed ID: 3119600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia associated with transitional cell carcinoma without bone metastases: description of two cases.
    Harel G; Gafter U; Zevin D; Chagnac A; Kimche D
    Urol Int; 1985; 40(3):164-5. PubMed ID: 4012911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.
    Inoue K; Karashima T; Fukata S; Nomura A; Kawada C; Kurabayashi A; Furihata M; Ohtsuki Y; Shuin T
    Clin Cancer Res; 2005 Sep; 11(18):6669-77. PubMed ID: 16166446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells.
    Bringhurst FR; Bierer BE; Godeau F; Neyhard N; Varner V; Segre GV
    J Clin Invest; 1986 Feb; 77(2):456-64. PubMed ID: 3003159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesions of bone and bladder cancer.
    Mullin EM; Glenn JF; Paulson DF
    J Urol; 1975 Jan; 113(1):45-6. PubMed ID: 1113395
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostaglandin-mediated hypercalcemia in transitional cell carcinoma of the bladder.
    McKay HA; Gavrell GJ; Meehan WL; Kaplan RA; Le Blanc GA
    J Urol; 1978 May; 119(5):689-92. PubMed ID: 660746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene modification of bladder cancer cells for the establishment of bladder cancer vaccine.
    Saito S; Tazaki H; Heston WD; Fair WR
    Int J Urol; 1996 Jan; 3(1 Suppl):S35-9. PubMed ID: 24304018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A model of orthotopic transplantation in mice using MBT-2].
    Sasaki A; Miyanaga N; Ohtani M; Koiso K; Nemoto R; Takanashi R
    Nihon Hinyokika Gakkai Zasshi; 1991 Sep; 82(9):1461-5. PubMed ID: 1942706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
    Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of interleukin-12 against murine bladder cancer.
    Eto M; Harada M; Tamada K; Tokuda N; Koikawa Y; Nakamura M; Nomoto K; Naito S
    J Urol; 2000 May; 163(5):1549-52. PubMed ID: 10751886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of transplantation site on metastatic ability of mouse bladder carcinoma sublines.
    Klaunig JE; Barut BA
    J Urol; 1988 Oct; 140(4):844-7. PubMed ID: 3418820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmetastatic bladder cancer associated with hypercalcemia, thrombocytosis and leukemoid reaction.
    Bennett JK; Wheatley JK; Walton KN; Watts NB; McNair O; O'Brien DP
    J Urol; 1986 Jan; 135(1):47-8. PubMed ID: 3941466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed.
    Khandaker MH; Kadhim SA; Ichim TE; Howson-Jan K; Chin J; Singhal SK
    Anticancer Res; 2000; 20(1A):183-9. PubMed ID: 10769653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.